Project Grant R01AG098889
- Federal Project Grant Award Summary Yale University received a $461,146 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded on May 15, 2025, with completion targeted for April 30, 2027. The award funds research investigating the dysregulation of cortical astrocytes in Alzheimer's disease (AD) models. The primary deliverable is novel scientific research employing advanced mesoscopic imaging techniques to longitudinally measure...
- Federal Project Grant Award Summary Yale University received a $190,374 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 1, 2025, through May 31, 2028. The award supports research investigating the immunological mechanisms underlying exercise's beneficial effects on skeletal muscle aging. The project delivers scientific research outputs examining how mechanical stress-induced inflammation in muscle stromal cells and...
- Federal Grant Award Summary Yale University received a $921,822 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded June 9, 2025, with completion targeted for May 31, 2027. The grant funds research investigating lysosomal regulation and functions of Tank-Binding Kinase 1 (TBK1) in neurodegenerative diseases, specifically amyotrophic lateral sclerosis and frontotemporal dementia. The research will deliver molecular and mechanistic insights...
- Federal Grant Award Summary Yale University received a $132,786 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded on August 15, 2025, with a completion date of June 30, 2027. The research investigates emotion network dysfunction and anxiety in early Alzheimer's disease (AD) by examining cortico-limbic circuit changes that distinguish healthy aging from AD-related cognitive decline. The project utilizes resting-state and task-based...
- Federal Grant Award Summary Yale University received a $4.9 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 14, 2025, with a completion date of June 30, 2029. The grant supports biomedical research investigating the mechanistic pathways by which gut microbiota and white adipose tissue control the CD4 T-cell compartment and facilitate T-cell migration from the...
- Federal Grant Award Summary Yale University received a $461,146 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded May 15, 2025, with completion targeted for April 30, 2027. The project, titled "Toward Developing a Navigation Model of the Aging Brain in the Marmoset," focuses on understanding the physiological function and organization of the entorhinal cortex (ERC) in marmosets to advance knowledge of Alzheimer's disease pathology...
- Federal Project Grant Award Summary Yale University received a $461,313 Project Grant award from the National Institute on Aging (Aging Research program, CFDA 93.866) effective June 1, 2025 through May 31, 2027. The grant supports research investigating the role of cysteine string protein alpha (CSPα) in presynaptic autophagy and its relationship to neurodegeneration. The project will generate scientific knowledge products including characterization of synaptic vesicles, autophagosomes, and...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $509,413 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 15, 2025, with completion targeted for May 31, 2030. The grant supports scientific research investigating epitranscriptomic regulation of microglia in Alzheimer's disease, focusing on understanding how m6A adenosine methylation in messenger RNA controls microglial cell function...
- Federal Grant Award Summary Yale University received a $1,624,822 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective May 15, 2025, through February 28, 2030. This grant supports a multimodal neuroimaging research study investigating sex-based contributors to vulnerability to Alzheimer's disease (AD). The research addresses the documented disparity that nearly two-thirds of AD patients are women and that women experience more...
- Federal Grant Award Summary New York University School of Medicine received a $3.1 million Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 15, 2025, through May 31, 2030. This research initiative examines the relationship between peripheral immune markers—specifically platelet aggregation and neutrophil activity—and vascular contributions to cognitive decline and dementia. The study integrates biofluid...
Yale University received a $746,160 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective March 20, 2026, with completion scheduled for February 28, 2031. The award funds research investigating the mechanisms by which peripheral inflammation contributes to cognitive decline and dementia risk in aging populations. The research will employ mouse models simulating common human inflammatory conditions—house dust mite (HDM)-induced respiratory allergy and dextran sulfate sodium (DSS)-induced colitis—to examine how acute and chronic inflammation alter microglial and neuronal activity in age-dependent ways. The primary deliverables include empirical research findings on the cellular and molecular mechanisms linking peripheral immune activation to neuroinflammatory responses, with specific focus on how aging modifies microglial sensitivity and neuronal connectivity. The project will advance understanding of the thresholds required to trigger neuroinflammatory responses that alter neuronal activity and identify age-dependent differences in these mechanisms. Results are expected to generate peer-reviewed publications and establish foundational knowledge for developing therapeutic interventions targeting the peripheral inflammation-dementia pathway in older adults.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $746.2k | 3/16/26 |